CA Patent

CA2894736C — Once daily formulations of tetracyclines

Assigned to Tcd Royalty Sub Lp · Expires 2019-07-16 · 7y expired

What this patent protects

Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory dis…

USPTO Abstract

Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2894736C
Jurisdiction
CA
Classification
—
Expires
2019-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Tcd Royalty Sub Lp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.